India
· Delayed Price · Currency is INR SMS Pharmaceuticals Statistics
Total Valuation
NSE:SMSPHARMA has a market cap or net worth of INR 20.89 billion. The enterprise value is 23.66 billion.
| Market Cap | 20.89B |
| Enterprise Value | 23.66B |
Important Dates
The next estimated earnings date is Tuesday, May 27, 2025.
| Earnings Date | May 27, 2025 |
| Ex-Dividend Date | Sep 23, 2024 |
Share Statistics
NSE:SMSPHARMA has 88.65 million shares outstanding. The number of shares has decreased by -0.31% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 88.65M |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 46.96% |
| Owned by Institutions (%) | 2.43% |
| Float | 45.35M |
Valuation Ratios
The trailing PE ratio is 30.14.
| PE Ratio | 30.14 |
| Forward PE | n/a |
| PS Ratio | 2.68 |
| PB Ratio | 3.71 |
| P/TBV Ratio | 3.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 35.79 |
| EV / Sales | 3.03 |
| EV / EBITDA | 17.81 |
| EV / EBIT | 23.23 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.19 |
| Debt / FCF | n/a |
| Interest Coverage | 5.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.72% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 6.52M |
| Profits Per Employee | 552,206 |
| Employee Count | 1,197 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.50% in the last 52 weeks. The beta is 1.23, so NSE:SMSPHARMA's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | +13.50% |
| 50-Day Moving Average | 208.72 |
| 200-Day Moving Average | 263.17 |
| Relative Strength Index (RSI) | 60.59 |
| Average Volume (20 Days) | 186,297 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SMSPHARMA had revenue of INR 7.80 billion and earned 660.99 million in profits. Earnings per share was 7.82.
| Revenue | 7.80B |
| Gross Profit | 2.47B |
| Operating Income | 990.95M |
| Pretax Income | 882.82M |
| Net Income | 660.99M |
| EBITDA | 1.30B |
| EBIT | 990.95M |
| Earnings Per Share (EPS) | 7.82 |
Balance Sheet
The company has 90.66 million in cash and 2.85 billion in debt, giving a net cash position of -2.76 billion or -31.16 per share.
| Cash & Cash Equivalents | 90.66M |
| Total Debt | 2.85B |
| Net Cash | -2.76B |
| Net Cash Per Share | -31.16 |
| Equity (Book Value) | 5.64B |
| Book Value Per Share | 66.75 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 31.66%, with operating and profit margins of 12.70% and 8.47%.
| Gross Margin | 31.66% |
| Operating Margin | 12.70% |
| Pretax Margin | 11.31% |
| Profit Margin | 8.47% |
| EBITDA Margin | 16.60% |
| EBIT Margin | 12.70% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.17%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.31% |
| Shareholder Yield | 0.48% |
| Earnings Yield | 3.16% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on December 17, 2015. It was a forward split with a ratio of 10.
| Last Split Date | Dec 17, 2015 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |